Natixis
-
Ceva Sante Animale, the veterinary vaccines maker, expects to receive initial commitments to a €668m-equivalent term loan on Friday, as it seeks to refinance debt using an aggressive covenant-lite structure.
-
Hong Kong-listed Citic Pacific hit the market with a HK$8.8bn ($1.13bn) loan on the evening of March 17, with bankers on the transaction expecting a quick turnaround from lenders considering the deal in syndication.
-
Carrefour Banque managed to brave and overcome the broad market turmoil that set in during the second half of last week, pricing its €500m senior unsecured floating rate note to become the only European senior issuer in the market on Friday.
-
Olam International, which is the target of a proposed acquisition by Singapore’s Temasek Holdings, is expected to launch its $1.2bn fundraising into syndication on the week of March 24.
-
Elbech leaves IADB - New EQD head for Natixis - StanChart credit head out
-
A group of 15 banks are tipped to win the mandate for the new loan for agricultural products supplier Olam International, which is expected to be launched at a size of $1.2bn.
-
Areva, the French nuclear power construction group, issued a €750m nine year bond today that was solidly oversubscribed, but was not the blowout enjoyed by Teollisuuden Voima a week ago.
-
Natixis has hired Eric Le Brusq, the ex-global head of equities and derivatives sales at BNP Paribas in London, as global head of equity derivatives sales, also in London.
-
A group of 15 banks are tipped to win the mandate for the new loan for agricultural products supplier Olam International, which is expected to launch at $1.2bn.
-
Nordex signs guarantee facility — Eramet mandates for loan — Ceva Sante sets date
-
Credit Suisse drew in €3.3bn of demand for its €1.75bn five year deal, the biggest of 2014 as generous pricing and name recognition spurred demand. By contrast, La Caisse Centrale Desjardins du Quebec pulled in a relatively anaemic book €1.2bn for its inaugural legislative €1bn five year deal.
-
French veterinary vaccines maker Ceva Sante Animale will begin to market a €700m-equivalent refinancing term loan at bank meetings next week.